skip to Main Content

Study Identifies New Therapeutic Target for Most Common Type of Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.

The findings suggest ISL2, a transcription factor, can act as a tumor suppressor in pancreatic ductal adenocarcinoma (PDA) tumors and that its depletion reprograms PDA cells’ transcriptional and metabolic states. Read more . . . 


Back To Top